1 Department of Medicine III, LMU Hospital, Munich, Germany.
2 Université Catholique de Louvain, CHU UcL Namur, Yvoir, Belgium.
3 Department of Medicine II, Hematology/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.
4 INSERM U1245, Department of Hematology, Centre Henri Becquerel and Université de Rouen, France.
5 Skåne University and Lund University, Lund, Sweden.
6 Barts Cancer Institute, Queen Mary University of London, United Kingdom.
7 Lymphoma Unit, Department of Onco-hematology, IRCCS San Raffaele Scientific Institute, Milano, Italy.
8 Service Hematologie Clinique Therapie Cellulaire, CHU Amiens Picardie, Amiens, France.
9 Comprehensive Cancer Center Ulm (CCCU), Sektion CLL Klinik für Innere Medizin III, Universität Ulm, Germany.
10 School of Medicine, University of Nottingham, United Kingdom.
11 Clinical Hematology Department, ICO-Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Badalona, Spain.
12 Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands.
13 University Hospital Centre Zagreb and Medical School, University of Zagreb, Croatia.
14 HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
15 Experimentelle und Translationale päd. Hämatologie u Onkologie, Leitung der Bereiche Lymphome und Stammzelltransplantation, Universitätsklinikum Münster (UKM), Klinik für Kinder- und Jugendmedizin, Pädiatrische Hämatologie und Onkologie, Munich, Germany.
16 Institute of Experimental Cancer Research, CCC Ulm, University Hospital Ulm, Germany.
17 Clinical and Transplant Unit, University Hospital of Salamanca, Spain.
18 Department of Medicine at the University of Salamanca, Spain.
19 El Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.
20 Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
21 Department of Hematology, Oncology and Tumor Immunology, Charité, University Medical Center Berlin, Campus Benjamin Franklin, Berlin, Germany.
22 Berlin Institute of Health, Berlin, Germany.
23 Southampton NCRI/UK Experimental Cancer Medicines Centre, Faculty of Medicine, University of Southampton, United Kingdom.
24 Department of Laboratory Medicine and Pathology, Institute of Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.
25 Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.
26 Città di Lecce Hospital, GVM Care & Research, Lecce, Italy.
27 Département de Pathologie, Hôpital Henri Mondor, AP-HP, Créteil, France.
28 Clinical Trial Unit, Division of Hematology 1, AOU Città Della Salute e Della Scienza, University of Torino, Italy.
29 Università Vita Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy.
30 Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
31 Biotech Research & Innovation Centre (BRIC), University of Copenhagen, Denmark.
32 University Hospital Heidelberg, Internal Medicine V and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
33 Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam and LYMMCARE, Amsterdam, the Netherlands.
34 Department of Medicine I, Division of Oncology, Medical University of Vienna, Austria.
35 Pediatric Hematology Oncology, Sorbonne Université APHP/hôpital A Trousseau, Paris, France.
36 Service d'Hématologie, Clinique du Centre Hospitalier Universitaire (CHU) de Nantes, France.
37 Medical Department A for Hematology, Oncology and Pneumology, University Hospital Münster, Germany.
38 University of Helsinki and Helsinki University Hospital Comprehensive Cancer Centre, Helsinki, Finland.
39 Department of Hematology, Hospital Clínic de Barcelona, Spain.
40 Onco-hematology, Université de Paris and Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, France.
41 Complejo Asistencial Universitario de Salamanca, IBSAL, CIC, Universidad de Salamanca, Ciberonc, Salamanca, Spain.
42 Hematology Department, University Hospital Hotel-Dieu, Nantes, France.
43 Hospital de la Santa Creu I Sant Pau, Autonomous University of Barcelona, Spain.
44 Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France.
45 Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, United Kingdom.
46 St James's Institute of Oncology, Leeds, United Kingdom.
47 Department of Internal Medicine-Hematology and Oncology and Department of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University and University Hospital Brno, Czech Republic.
48 Klinisch-experimentelle Hämatologie, Medizinische Klinik II, Hämatologie und Internistische Onkologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Germany.
49 Medical University of Lodz, Poland.
50 Division of Medical Oncology and Immune-related Tumors, National Cancer Institute, Aviano, Italy.
51 Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
52 Department of Pediatric Hematology and Oncology 2nd Faculty of Medicine, Charles University Prague University Hospital, Prague, Czech Republic.
53 Immunology and Cell Therapy Lab at Rennes University Hospital, Rennes, France.
54 Department of Hematology, Niguarda Hospital Milano, Italy.
55 Department of Hemato-Oncology, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
56 Department of Internal Medicine II: Haematology and Oncology, DIAKO Hospital Bremen, Germany.
57 Hematology and Medical Oncology, University Medicine Goettingen, Germany.
58 Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, New York, NY, USA.